The Bern Birth Cohort (BeBiCo) to study the development of the infant intestinal microbiota in a high-resource setting in Switzerland: rationale, design, and methods

• Main Authors: Luca Cecchini (Author), Colette Barmaz (Author), Maria José Coloma Cea (Author), Hannah Baeschlin (Author), Julian Etter (Author), Stefanie Netzer (Author), Leonie Bregy (Author), Dmitrij Marchukov (Author), Nerea Fernandez Trigo (Author), Rachel Meier (Author), Jasmin Hirschi (Author), Jacqueline Wyss (Author), Andrina Wick (Author), Joelle Zingg (Author), Sandro Christensen (Author), Anda-Petronela Radan (Author), Annina Etter (Author), Martin Müller (Author), Michael Kaess (Author), Daniel Surbek (Author), Bahtiyar Yilmaz (Author), Andrew J. Macpherson (Author), Christiane Sokollik (Author), Benjamin Misselwitz (Author), Stephanie C. Ganal-Vonarburg (Author)
• Format: Book
• Published: BMC, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.1186/s12887-023-04198-5; 1471-2431
• Keywords: Intestinal microbiome; Microbiota maturation; 16S sequencing; Metagenomic sequencing; Breastfeeding; Immune maturation; Pediatrics; RJ1-570
• Source: BMC Pediatrics, Vol 23, Iss 1, Pp 1-16 (2023)

Abstract Background Microbiota composition is fundamental to human health with the intestinal microbiota undergoing critical changes within the first two years of life. The developing intestinal microbiota is shaped by maternal seeding, breast milk and its complex constituents, other nutrients, and the environment. Understanding microbiota-dependent pathologies requires a profound understanding of the early development of the healthy infant microbiota. Methods Two hundred and fifty healthy pregnant women (≥20 weeks of gestation) from the greater Bern area will be enrolled at Bern University hospital's maternity department. Participants will be followed as mother-baby pairs at delivery, week(s) 1, 2, 6, 10, 14, 24, 36, 48, 96, and at years 5 and 10 after birth. Clinical parameters describing infant growth and development, morbidity, and allergic conditions as well as socio-economic, nutritional, and epidemiological data will be documented. Neuro-developmental outcomes and behavior will be assessed by child behavior checklists at and beyond 2 years of age. Maternal stool, milk, skin and vaginal swabs, infant stool, and skin swabs will be collected at enrolment and at follow-up visits. For the primary outcome, the trajectory of the infant intestinal microbiota will be characterized by 16S and metagenomic sequencing regarding composition, metabolic potential, and stability during the first 2 years of life. Secondary outcomes will assess the cellular and chemical composition of maternal milk, the impact of nutrition and environment on microbiota development, the maternal microbiome transfer at vaginal or caesarean birth and thereafter on the infant, and correlate parameters of microbiota and maternal milk on infant growth, development, health, and mental well-being. Discussion The Bern birth cohort study will provide a detailed description and normal ranges of the trajectory of microbiota maturation in a high-resource setting. These data will be compared to data from low-resource settings such as from the Zimbabwe-College of Health-Sciences-Birth-Cohort study. Prospective bio-sampling and data collection will allow studying the association of the microbiota with common childhood conditions concerning allergies, obesity, neuro-developmental outcomes , and behaviour. Trial registration The trial has been registered at www.clinicaltrials.gov , Identifier: NCT04447742